CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE6273.5585.85 (+1.39 %)
PREV CLOSE () 6187.70
OPEN PRICE () 6240.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 477
TODAY'S LOW / HIGH ()6215.00 6322.65
52 WK LOW / HIGH ()4699.7 6701.4
NSE6287.0080 (+1.29 %)
PREV CLOSE() 6207.00
OPEN PRICE () 6210.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 6287.00 (12)
VOLUME 11828
TODAY'S LOW / HIGH() 6205.00 6333.00
52 WK LOW / HIGH ()4707 6739
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1967

Management Info :

S Madhavan - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),
Mumbai,
Maharashtra-400099

Phone : 022 68669000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
04Jun Procter & Gamble Health informs about
Procter & Gamble Health has informed that the management of the Comp..
26Aug Procter & Gamble Health re-submits an
With reference to its earlier communication dated August 6, 2025, Procte..
06Aug Procter & Gamble Health informs about
Procter & Gamble Health has informed that it enclosed the Business R..
06Aug Procter & Gamble Health informs about
Procter & Gamble Health has informed that it enclosed the Annual Rep..
17Jun Procter & Gamble Health informs about
With reference to the virtual connect with analysts/ institutional inves..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit9463269.1
Gross Profit 1332.1 4498.6
Operating Profit 1395.94740
Net Sales 3704.514079.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
 3063.60 (12.85%)
M.Cap ( in Cr)
1892.70
Neuland Laboratories (BSE)
 17177.50 (1.33%)
M.Cap ( in Cr)
22038.54
Abbott India (BSE)
 26272.05 (0.76%)
M.Cap ( in Cr)
55826.27
Senores Pharmaceutic (BSE)
 1291.25 (11.35%)
M.Cap ( in Cr)
5946.67
Kwality Pharma (BSE)
 2497.00 (5.24%)
M.Cap ( in Cr)
2590.94
Shareholding Pattern
PROMOTERS 51.82%
NON-INSTITUTION 28.31%
MUTUAL FUNDS/UTI 10.2%
FI/BANKS/INSURANCE 3.34%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75527.951695.40 (2.30%)
NIFTY23622.90461.30 (1.99%)
Dow Jones 51202.26353.51 (0.70%)
Nasdaq 25888.8479.18 (0.31%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI